Matinas Biopharma Q2 2025 Earnings Report: Deep Losses, But Backtests Suggest A Path ...

Retrieved on: 2025-08-17 17:00:06

Tags for this article:

Click the tags to see associated articles and topics

Matinas Biopharma Q2 2025 Earnings Report: Deep Losses, But Backtests Suggest A Path .... View article details on hiswai:

Excerpt

- Matinas Biopharma (MTNB) reported a $11.54M Q2 2025 net loss with $2.47/share deficit, driven by high R&D and operating costs. - Historical ...

Article found on: www.ainvest.com